A detailed history of Future Financial Wealth Managment LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Future Financial Wealth Managment LLC holds 6,420 shares of ABBV stock, worth $1.09 Million. This represents 0.92% of its overall portfolio holdings.

Number of Shares
6,420
Previous 6,415 0.08%
Holding current value
$1.09 Million
Previous $1.1 Million 15.18%
% of portfolio
0.92%
Previous 0.98%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$163.84 - $199.33 $819 - $996
5 Added 0.08%
6,420 $1.27 Million
Q2 2024

Jul 16, 2024

SELL
$154.79 - $180.76 $45,508 - $53,143
-294 Reduced 4.38%
6,415 $1.1 Million
Q1 2024

Apr 15, 2024

SELL
$159.82 - $182.1 $42,671 - $48,620
-267 Reduced 3.83%
6,709 $1.22 Million
Q4 2023

Jan 18, 2024

SELL
$137.6 - $154.97 $26,556 - $29,909
-193 Reduced 2.69%
6,976 $1.08 Million
Q3 2023

Oct 20, 2023

BUY
$133.59 - $154.65 $935 - $1,082
7 Added 0.1%
7,169 $1.07 Million
Q2 2023

Jul 18, 2023

BUY
$132.51 - $164.9 $25,839 - $32,155
195 Added 2.8%
7,162 $964,000
Q1 2023

Apr 04, 2023

SELL
$144.61 - $166.54 $196,524 - $226,327
-1,359 Reduced 16.32%
6,967 $1.11 Million
Q4 2022

Jan 05, 2023

BUY
$138.31 - $165.87 $18,256 - $21,894
132 Added 1.61%
8,326 $0
Q3 2022

Oct 13, 2022

SELL
$134.21 - $153.93 $66,299 - $76,041
-494 Reduced 5.69%
8,194 $1.26 Million
Q1 2022

May 03, 2022

SELL
$131.98 - $163.75 $12,406 - $15,392
-94 Reduced 1.07%
8,688 $1.41 Million
Q4 2021

Jan 07, 2022

BUY
$107.43 - $135.93 $1,396 - $1,767
13 Added 0.15%
8,782 $1.19 Million
Q2 2021

Aug 04, 2021

BUY
$105.21 - $117.21 $736 - $820
7 Added 0.08%
8,769 $988,000
Q1 2021

May 05, 2021

BUY
$102.3 - $112.62 $16,061 - $17,681
157 Added 1.82%
8,762 $948,000
Q4 2020

Feb 03, 2021

BUY
$80.49 - $108.67 $692,616 - $935,105
8,605 New
8,605 $922,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $301B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Future Financial Wealth Managment LLC Portfolio

Follow Future Financial Wealth Managment LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Future Financial Wealth Managment LLC, based on Form 13F filings with the SEC.

News

Stay updated on Future Financial Wealth Managment LLC with notifications on news.